Indications
Treatment of primary and recurrent severe genital herpes (including in patients with impaired immunity) – orally and parenterally;
– prevention is often recurrent (6 or more cases per year) genital herpes (including in patients with impaired immunity) – inside;
-treatment of primary and recurrent herpes simplex with lesions of skin and mucous membranes caused by Herpes simplex virus 1 and 2, in patients with impaired immunity orally, parenterally;
prophylaxis of herpes simplex in patients with impaired immunity (including after transplantation and the treatment of immunosuppressive drugs, HIV-infected patients on chemotherapy) – inside;
– encephalitis caused by Herpes simplex virus 1 and 2 type – parenteral;
– the treatment of herpes zoster, caused by Varicella zoster virus in adults – inside; in patients with impaired immunity and generalized herpes zoster in patients with intact immunity – parenteral;
– prevention of herpes zoster, caused by Varicella zoster virus, after an initial period of use of acyclovir for parenteral use in all patients with impaired immunity (including after transplantation and in the treatment of immunosuppressive drugs, HIV-infected patients on chemotherapy) – inside;
– herpes zoster with eye disease – orally, parenterally;
generalized infection in neonates caused by Herpes simplex virus – parenteral;
– varicella in patients with intact immunity within 24 hours after the onset of the rash typical of the interior, in patients with impaired immunity – parenteral.
Reviews
There are no reviews yet